Overall, compared to the acute lymphoid leukemia cell line Jurkat in our previous studies [40], ovarian cancer cells have about 2–8 times more BCLXL and 8–50 times more MCL1, but much less BCL2 (Supplemental Fig. 6a). This evidence concerns the gene BCL2 and ovarian carcinoma.